• Explore /
  • Poster
  • / XELOX or mFOLFOX6 chemotherapy combined with resection of primary lesion versus chemotherapy alone for colon cancer with unresectable metastases: A randomized clinical trial.

XELOX or mFOLFOX6 chemotherapy combined with resection of primary lesion versus chemotherapy alone for colon cancer with unresectable metastases: A randomized clinical trial.

Abstract Poster

Authors

null

Weijian Guo

Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Weijian Guo , Xinxiang Li , Mingzhu Huang , Ya'nan Yang , Qingguo Li , Chenchen Wang , Lei Liang , Xiaodong Zhu , Wen Zhang , Zhiyu Chen , Wenhua Li , Xiaowei Zhang , Xiaoying Zhao , Lixin Qiu , Qirong Geng , Xuedan Sheng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT02291744

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3590)

DOI

10.1200/JCO.2021.39.15_suppl.3590

Abstract #

3590

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Lin Shen

First Author: Qi Lin

First Author: Hiroyuki Ohnuma

First Author: Syu Tanimura